Management options for nonalcoholic steatohepatitis are limited. Lanifibranor showed promise against markers of NASH activity in preclinical studies, but its efficacy remained unknown. https://t.co/BEqOjpvqtp
@Inside_TheMatch Does anyone else think it’s disrespectful to say it’s my honor to be rejected by such and such program? Why wasting other people’s time and your own money to take pride in a rejection?
Every time I google FRIEDA, I get to see Frieda Khalo and her work. I hope MATCH 2022 goes as smoothly as her beautiful single eyebrow! Good luck everyone! #FRIEDA#singleeyebrow
@JanakPatelMed@Inside_TheMatch Hey Dr. Patel I am very excited to follow your steps in the match! I need some guidance during application and communication with programs.